ahlam1399
09-23-2015, 07:41 PM
GSK may get EU green light for new biotech asthma drug this week
LONDON, Sept 23 (Reuters) - GlaxoSmithKline may get a green light from European regulators as early as this week for a new biotech medicine to treat severe asthma, boosting prospects for its struggling respiratory business.
http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2.img (http://da.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/ach.img (http://adchoice.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/ach.htm)http://pi.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a1a61b1/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=1Z3_OeJE34s:mkLZ2wO-tmU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1Z3_OeJE34s:mkLZ2wO-tmU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=1Z3_OeJE34s:mkLZ2wO-tmU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1Z3_OeJE34s:mkLZ2wO-tmU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=1Z3_OeJE34s:mkLZ2wO-tmU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/1Z3_OeJE34s
LONDON, Sept 23 (Reuters) - GlaxoSmithKline may get a green light from European regulators as early as this week for a new biotech medicine to treat severe asthma, boosting prospects for its struggling respiratory business.
http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2.img (http://da.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/ach.img (http://adchoice.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/ach.htm)http://pi.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238386275986/u/49/f/654213/c/35217/s/4a1a61b1/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a1a61b1/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=1Z3_OeJE34s:mkLZ2wO-tmU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1Z3_OeJE34s:mkLZ2wO-tmU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=1Z3_OeJE34s:mkLZ2wO-tmU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1Z3_OeJE34s:mkLZ2wO-tmU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=1Z3_OeJE34s:mkLZ2wO-tmU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/1Z3_OeJE34s